Research Article
Efficacy and Safety of Chuanxiong Qingnao Granule in Patients with Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial
Table 4
Efficacy measurements of participants at week 24.
| Characteristic | Treatment (n = 172) | Control (n = 174) | value |
| Percentage of patients with ≥50% reduction in frequency of headache, n (%) | 143 (83.1) | 6 (3.4) | <0.001 | Frequency of headache attack, mean (SD) | 2.16 ± 1.09 | 5.68 ± 1.10 | <0.001 | Days of headache attack, mean (SD) | 3.31 ± 1.40 | 7.05 ± 1.05 | <0.001 | VAS, mean (SD) | 3.12 ± 1.57 | 6.37 ± 1.48 | <0.001 | FSS, mean (SD) | 15.98 ± 7.18 | 30.77 ± 7.92 | <0.001 | HAMD, mean (SD) | 10.85 ± 4.46 | 19.84 ± 6.89 | <0.001 | MIDAS, mean (SD) | 8.40 ± 3.32 | 19.13 ± 4.97 | <0.001 |
|
|